OMER Q1 2021 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$835M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$390,000

Operating Income

-$45M

Net Income

-$35M

EPS (Diluted)

$-0.57

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$40M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$161M

Total Liabilities

$383M

Stockholders' Equity

-$222M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$24M	-100.0%
Gross Profit	-$390,000	$23M	-101.7%
Operating Income	-$45M	-$24M	-91.3%
Net Income	-$35M	-$29M	-20.9%